Volume 24, Issue 3, Pages (September 2016)

Slides:



Advertisements
Similar presentations
Making Proteins in the Powerhouse B. Martin Hällberg, Nils-Göran Larsson Cell Metabolism Volume 20, Issue 2, Pages (August 2014) DOI: /j.cmet
Advertisements

Volume 14, Issue 6, Pages (December 2011)
Volume 2, Issue 4, Pages (October 2005)
The Glucocorticoid Receptor Controls Hepatic Dyslipidemia through Hes1
Volume 13, Issue 4, Pages (April 2011)
Volume 19, Issue 4, Pages (April 2014)
Volume 14, Issue 1, Pages (July 2011)
Volume 17, Issue 12, Pages (December 2016)
Volume 16, Issue 12, Pages (September 2016)
Volume 15, Issue 4, Pages (April 2012)
Volume 35, Issue 5, Pages (December 2015)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Volume 17, Issue 4, Pages (April 2013)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 24, Issue 6, Pages (December 2016)
Volume 6, Issue 3, Pages (September 2007)
Volume 6, Issue 3, Pages (September 2007)
Estrogen Deficiency Promotes Hepatic Steatosis via a Glucocorticoid Receptor- Dependent Mechanism in Mice  Matthew A. Quinn, Xiaojiang Xu, Melania Ronfani,
Volume 15, Issue 2, Pages (February 2012)
Volume 11, Issue 4, Pages (April 2010)
Volume 12, Issue 4, Pages (October 2010)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 2, Issue 2, Pages (August 2005)
Volume 17, Issue 5, Pages (May 2013)
Volume 7, Issue 3, Pages (March 2008)
Volume 24, Issue 4, Pages (October 2016)
Volume 23, Issue 4, Pages (April 2016)
Volume 13, Issue 8, Pages (November 2015)
Volume 60, Issue 4, Pages (November 2015)
Volume 18, Issue 6, Pages (December 2013)
Volume 16, Issue 12, Pages (September 2016)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
Volume 2, Issue 5, Pages (November 2005)
Volume 29, Issue 3, Pages (May 2014)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 16, Issue 2, Pages (August 2012)
Volume 136, Issue 6, Pages (March 2009)
Volume 9, Issue 5, Pages (May 2009)
Volume 6, Issue 5, Pages (November 2007)
Volume 17, Issue 8, Pages (November 2016)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 10, Issue 5, Pages (November 2009)
Volume 11, Issue 3, Pages (March 2010)
Volume 8, Issue 2, Pages (August 2008)
Volume 14, Issue 1, Pages (July 2011)
Volume 9, Issue 6, Pages (December 2014)
Volume 18, Issue 1, Pages (July 2013)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 29, Issue 5, Pages (March 2008)
Volume 16, Issue 2, Pages (August 2012)
Volume 21, Issue 3, Pages (March 2015)
Volume 15, Issue 6, Pages (June 2012)
Volume 3, Issue 1, Pages (January 2006)
Volume 21, Issue 2, Pages (February 2015)
PAS Kinase Drives Lipogenesis through SREBP-1 Maturation
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Circadian Dysfunction Induces Leptin Resistance in Mice
Volume 40, Issue 4, Pages (April 2014)
Volume 27, Issue 4, Pages e4 (April 2018)
Cbx4 Sumoylates Prdm16 to Regulate Adipose Tissue Thermogenesis
Volume 7, Issue 3, Pages (March 2008)
Volume 4, Issue 5, Pages (November 2006)
Volume 17, Issue 2, Pages (February 2013)
Volume 49, Issue 2, Pages (January 2013)
Volume 17, Issue 5, Pages (May 2013)
Volume 9, Issue 4, Pages (April 2009)
Volume 24, Issue 6, Pages (December 2016)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Volume 1, Issue 5, Pages (May 2005)
Presentation transcript:

Volume 24, Issue 3, Pages 474-484 (September 2016) SETDB2 Links Glucocorticoid to Lipid Metabolism through Insig2a Regulation  Manuel Roqueta-Rivera, Ryan M. Esquejo, Peter E. Phelan, Katalin Sandor, Bence Daniel, Fabienne Foufelle, Jun Ding, Xiaoman Li, Sepideh Khorasanizadeh, Timothy F. Osborne  Cell Metabolism  Volume 24, Issue 3, Pages 474-484 (September 2016) DOI: 10.1016/j.cmet.2016.07.025 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 SETDB2 Is a Glucocorticoid-Responsive Gene (A) Liver Setdb2 mRNA and SETDB2 nuclear immunoblot in refed versus fasted liver. (B) Setdb2 mRNA in MPHs treated with various stress/fasting-related compounds. (C) Liver Setdb2 induction by DEX is GR dependent. (D) GR and SETDB2 interact in MPHs. (E) SETDB2 and GR immunofluorescence in Hepa1-6. ∗p < 0.05 relative to control, n = 4–6. RF, refed; F, fast; DB2, SETDB2. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 SETDB2 Is Required for Dex-Mediated Activation of Select GR Targets (A) Pie chart of SETDB2-GR co-regulated genes. (B) SETDB2 immunoblot of liver nuclear protein and mRNA in mice infected with shControl (shCtrl) or shSETDB2 (shDB2) adenovirus. (C and D) Liver mRNA and GR-ChIP qPCR at promoters of (C) Tat and (D) Cyp2b10. n = 3. Groups with different letters are statistically different, p < 0.05. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 SETDB2 and GR Are Required for Dex-Mediated Activation of Insig2a (A) Liver Insig2a mRNA from mice infected with adenovirus (Ad)-shControl (shCtrl), shSETDB2 (shDB2), and shGR in presence or absence of Dex. (B) Insig2 gene track showing Dex-responsive DNase and GR binding site at −1.6 kb TSS. (C and D) (C) GR ChIP-qPCR and (D) SETDB2 ChIP-qPCR at Insig2a promoter. Groups with different letters are statistically different, p < 0.05. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 SETDB2 Does Not Correlate with H3K9 Methylation at Promoters of Dex-Induced GR Targets ChIP-qPCR at promoters of SETDB2-GR regulated genes. (A) GR. (B) SETDB2. (C) H3K9me3. (D) H3K4me3. ∗p < 0.05 relative to vehicle treatment. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 5 Long-Range Chromatin Interaction of Enhancer-Promoter at Lcn2 (A) Liver Lcn2 mRNA. (B) GR and SETDB2 ChIP-qPCR at Lcn2 promoter. (C) GR-ChIP qPCR at Lcn2 enhancer. (D) RAD21-ChIP qPCR at Lcn2 promoter. (E) 3C-qPCR at Lcn2 locus from wild-type (WT) and SETDB2-deficient mouse livers (DB2GT) ± DEX. (F) 3C-qPCR at Lcn2 locus from mouse liver with restored SETDB2 (DB2FLP) in presence of Dex. Groups with different letters are statistically different, p < 0.05. ∗p < 0.05 versus control. Bait for 3C-qPCR spans Lcn2 promoter from TSS to −1.5 kb TSS. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 6 Long-Range Chromatin Interaction of Enhancer-Promoter at Insig2 (A) GR and SETDB2 ChIP-qPCR at Insig2 enhancer in livers lacking SETDB2 or GR. (B) Insig2 enhancer RNA of mouse liver in response to Dex. (C) 3C qPCR at Insig2 locus from wild-type and SETDB2 gene trap mouse livers ± DEX. ∗p < 0.05 relative to shControl + PBS or wild-type (WT) PBS. Bait for 3C-qPCR spans Insig2a promoter from TSS to −8 kb TSS. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 7 Dex Inhibition of SREBP Processing during Refeeding (A) Liver immunoblot of nuclear SREBP1/2 during a fasted or refed state ± Dex. (B) Liver immunoblot during refed state ± DEX in mice infected with shControl (shCtrl), shSETDB2 (shDB2), and shINSIG2. n = pool of three mice. (C) Dex inhibition of SREBP processing in Ob/Ob liver. N, nuclear; M, membrane. Each lane in (A) and (C) represents protein from individual mice. (D) Liver TAG (n = 4) from 10-week-old Ob/Ob mice treated with PBS or Dex (10 mg/kg body weight) for 3 days via intraperitoneal injection at ZT 10; ∗p < 0.05. Data are represented as mean ± SEM. Cell Metabolism 2016 24, 474-484DOI: (10.1016/j.cmet.2016.07.025) Copyright © 2016 Elsevier Inc. Terms and Conditions